The Prime Minister announced that 21st June onwards, the Government of India will provide free vaccines to all Indian citizens above 18 years of age
The DREAM-ND Phase III trial has now enrolled 588 CKD patients not-on-dialysis.
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
A major push to sharpen the future of cancer treatment is underway
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
The company says the platform offers improved manufacturability and functional advantages
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
Subscribe To Our Newsletter & Stay Updated
